Bionime is a pioneer and influencer of the highest standards in the blood glucose meter industry. As early as 2009, in a market accuracy survey conducted by the Institute for Diabetes-Technology (IDT) at the University of Ulm, Germany,
Bionime’s product achieved the highest standard and was honored as the top-ranking global brand in blood glucose meter testing accuracy. Its quality surpassed that of other European and American brands.

In 2019, Bionime’s product once again achieved the highest level of accuracy among commercially available blood glucose meters in an IDT survey report.
 
Recently, Bionime reached a significant milestone in October 2023 by obtaining TFDA approval to sell the Rightest iFree CGM (Continuous Glucose Monitoring) as a second-class medical device. This achievement highlights that Bionime will continue to provide more comprehensive products for diabetes care.


If you are interested in learning more about how Bionime’s products and techniques surpass international standards and our future development prospects, please join us at Arab Health 2024!
We look forward to sharing more information with you!

Connect with us at Bionime Corporation, and on LinkedIn at https://www.linkedin.com/company/bionime